Recurrent hepatitis C posttransplant: Early preservation injury may predict poor outcome

Liver Transplantation

Volumn 12, Issue 1, 2006, Pages 134-139

  Watt, Kymberly D S ^a,c   Lyden, Elizabeth R ^b   Gulizia, James M ^b   McCashland, Timothy M ^b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CYCLOSPORIN; TSUKUBAENOLIDE;

ADULT; AGE; ARTICLE; CONTROLLED STUDY; DEATH; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER BIOPSY; LIVER FAILURE; LIVER FIBROSIS; LIVER INJURY; LIVER ISCHEMIA; LIVER PRESERVATION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; ORGAN DONOR; PREDICTION; PRIORITY JOURNAL; RECURRENT INFECTION; RISK FACTOR; SEX DIFFERENCE; SURVIVAL RATE; TIME; TREATMENT OUTCOME; UNITED STATES; UNIVARIATE ANALYSIS;

BIOPSY, NEEDLE; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; GRAFT REJECTION; HEPATITIS C, CHRONIC; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; LIVER FAILURE; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATIONS; PROBABILITY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECURRENCE; REFERENCE VALUES; REPERFUSION INJURY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TRANSPLANTATION IMMUNOLOGY;

EID: 33645101411     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.20583     Document Type: Article

References (12)

1. Busquets J, Figueras J, Serrano T, Torras J, Ramos E, Rafecas A, et al. Postreperfusion biopsies are useful in predicting complications after liver transplantation. Liver Transpl 2001;7:432-435.
2. Lee YM, Obrien CB, Yamashiki N, Behro M, Weppler D, Tzakis AG, Schiff ER. Preservation injury patterns in liver transplantation associated with poor prognosis. Transpl Proc 2003;35:2964-2966.
3. Ghobrial RM, Steadman R, Gornbein J, Lassman C, Holt CD, Chen P, et al. A ten year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patients. Ann Surg 2001;234:384-394.
4. Charlton M, Seaberg E, Wiesner R, Everhart J, Zetterman R, Lake J, et al. Predictors of patient and graft survival following liver transplantation for hepatitis C. Hepatology 1998;28:823-830.
5. Baron PW, Sindram D, Higdon D, Howell D, Gottfried MR, Tuttle-Newhall JE, Clavien PA. Prolonged rewarming time during allograft implantation predisposes to recurrent hepatitis C infection after liver transplantation. Liver Transpl 2000;6:407-412.
6. Baltz AC, Trotter JF. Living donor liver transplantation and hepatitis C. Clin Liver Dis 2003;7:651-665.
7. Velidedeoglu E, Mange KC, Frank A, Abt P, Desai NM, Markmann JW, et al. Factors differentially correlated with the outcome of liver transplantation in HCV+ and HCV-recipients. Transplantation 2004;77:1834-1842.
8. Accatino L, Pizarro M, Solis N, Arrese M, Koenig CS. Bile secretory function after warm hepatic ischemia-reperfusion injury in the rat. Liver Transpl 2003;9:1199-1210.
9. Kukan M, Haddad PS. Role of hepatocytes and bile duct cells in preservation-reperfusion injury of liver grafts. Liver Transpl 2001;7:381-400.
10. Dickson RC, Caldwell SH, Ishitani MB, Lau JY, Driscoll CJ, Stevenson WC, et al. Clinical and histologic patterns of early graft failure due to recurrent hepatitis C in four patients after liver transplantation. Transplantation 1996; 61:701-705.
11. Taga SA, Washington MK, Terrault N, Wright TL, Somberg KA, Ferrell LD. Cholestatic hepatitis C in liver allografts. Liver Transpl Surg 1998;4:304-310.
12. Cotler SJ, Taylor SL, Gretch DR, Bronner MP, Rizk R, Perkins JD, Carithers PL Jr. Hyperbilirubinemia and cholestatic liver injury in hepatitis C-infected liver transplant recipients. Am J Gastroenterol 2000;95:753-759.